MedTrace Logo

Airway Clearance Study

NCT00379028 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2011-01-24

No results posted yet for this study

Summary

The purpose of the study is to evaluate how the airways in COPD patients, compared to healthy volunteers, absorb steroid drugs from Symbicort Turbuhaler and Seretide Diskus. The blood concentrations of the steroids will be used as surrogate marker.

Conditions

Interventions

DRUG

Budesonide/Formoterol Turbuhaler

DRUG

Salmeterol/Fluticasone Diskus

Sponsors & Collaborators

Principal Investigators

  • Christer Hultquist, MD · AstraZeneca

  • Tim Harrisson, MD · Nottingham University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-09-30
Completion
2007-07-31

Countries

  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00379028 on ClinicalTrials.gov